MAM
ODT

Martingale Asset Management’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Martingale Asset Management’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-35,300
Closed -$1.5M – 1122
2020
Q2 		$1.5M Buy
+35,300
New +$1.14M 0.02% 621

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Martingale Asset Management's ODT Position: Q3 2020 in Review

Martingale Asset Management sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q3 2020, closing a stake of 35,300 shares — an estimated $1.5M sold.

Martingale Asset Management first reported a position in ODT in Q2 2020 and held it in 1 quarter. The position peaked at $1.5M in Q2 2020. 89 funds tracked by Wall St. Rank hold ODT as of Q3 2020.

  • Martingale Asset Management reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Martingale Asset Management sold 35,300 Odonate Therapeutics, Inc. Common Stock shares in Q3 2020, an estimated $1.5M.
  • Martingale Asset Management first reported a position in Odonate Therapeutics, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Martingale Asset Management's Odonate Therapeutics, Inc. Common Stock position peaked at $1.5M in Q2 2020.
  • 89 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q3 2020.

Based on Martingale Asset Management's 13F filing for Q3 2020, filed 12 Nov 2020.